The UMKC Health Sciences District (HSD) Research Council is focused on addressing substance use disorders (SUD) and the national opioid epidemic. Our goal is to foster collaboration between UMKC Health Sciences District members so that focused cross-disciplinary approaches to these can be developed.

We invite you to review the following list of funding opportunities that may be of interest to opioid researchers.  To add other opportunities to this list, please email us: Info@UMKCHealthSciencesDistrict.org

This information is abstracted for brevity; please refer to the sponsor’s website for complete information.

Funding Opportunities (as of March 15, 2019):

 

Funding Opportunities (as of Feb 7, 2019) :

NIH TITLE

FOA

Org

Expires

Activity Code

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3 Clinical Trial Required)

RFA-AR-19-029

NIAMS

Feb 26, 2019

UG3/UH3

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed)

RFA-DA-19-023

NIDA

Feb 27, 2019

U2C

HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional)

RFA-HL-19-029

NHLBI

Feb 27, 2019

U01

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional)

RFA-DA-19-024

NIDA

Feb 27, 2019

U2C

HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 – Clinical Trial Not Allowed)

RFA-HL-19-028

NHLBI

Feb 27, 2019

R01

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical Trial Optional)

RFA-DA-19-025

NIDA

Feb 27, 2019

UG1

Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional)

RFA-NS-19-009

NINDS

Feb 28, 2019

R21

Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)

RFA-AT-19-001

NCCIH

Feb 28, 2019

R61/R33

Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional)

RFA-NS-19-008

NINDS

Feb 28, 2019

R01

HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)

RFA-TR-19-003

NCATS

Feb 28, 2019

UG3/UH3

HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed)

RFA-TR-19-005

NCATS

Feb 28, 2019

UH2/UH3

Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)

RFA-NS-19-010

NINDS

Mar 6, 2019

UG3/UH3

HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain – (U44 Clinical Trial Not Allowed)

RFA-NS-19-020

NINDS

Mar 6, 2019

U44

HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) Initiative (U24 Clinical Trial Not Allowed)

RFA-DA-19-034

NIDA

Mar 13, 2019

U24

HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required)

RFA-DA-19-035

NIDA

Mar 13, 2019

UG3/UH3

HEAL Initiative Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R01, Clinical Trials Optional)

RFA-AT-19-007

NCCIH

Mar 15, 2019

R01

Heal Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)

RFA-AT-19-005

NCCIH

Mar 15, 2019

UG3/UH3

Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional)

RFA-AT-19-008

NCCIH

Mar 15, 2019

R01

Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional)

RFA-AT-19-009

NCCIH

Mar 15, 2019

R21

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Mechanistic Research Centers (U19 Clinical Trial Optional)

RFA-AR-19-026

NIAMS

Mar 20, 2019

U19

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center (U24 Clinical Trial Not Allowed)

RFA-AR-19-027

NIAMS

Mar 20, 2019

U24

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3 Clinical Trial Optional)

RFA-AR-19-028

NIAMS

Mar 20, 2019

UH2/UH3

Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 – Clinical Trial Optional)

RFA-DA-19-032

NIDA

Mar 20, 2019

R41/R42

Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 – Clinical Trial Optional)

RFA-DA-19-033

NIDA

Mar 20, 2019

R43/R44

HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34- Clinical Trial Not Allowed)

RFA-DA-19-029

NIDA

Mar 25, 2019

R34

HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) ( R34- Clinical Trial Not Allowed)

RFA-DA-19-036

NIDA

Mar 25, 2019

R34

HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium – Clinical Centers (U01 Clinical Trial Required)

RFA-DK-18-030

NIDDK

Mar 27, 2019

U01

HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium – Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-18-031

NIDDK

Mar 27, 2019

U01

HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trials Not Allowed)

RFA-HD-19-025

NICHD

Mar 29, 2019

PL1

Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18)

RFA-HS-19-001

AHRQ

Mar 31, 2019

R18

HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required)

RFA-MH-19-525

NIMH

Apr 1, 2019

U01

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

PA-18-574

NIH

Apr 5, 2019

R43/R44

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

PA-18-575

NIH

Apr 5, 2019

R41/R42

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

PA-18-576

NIH

Apr 5, 2019

R41/R42

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

PA-18-573

NIH

Apr 5, 2019

R43/R44

Prescription Drug Abuse (R01 Clinical Trial Optional)

PA-18-058

NIDA

May 7, 2019

R01

Prescription Drug Abuse (R21 Clinical Trial Optional)

PA-18-076

NIDA

May 7, 2019

R21

Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)

PA-18-141

NINR

May 7, 2019

R01

Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)

PA-18-159

NINR

May 7, 2019

R21

Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)

RFA-HD-19-024

NICHD

May 14, 2019

R01

Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed)

PAR-18-331

NIMHD

Jun 7, 2019

R01

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01)

PAR-17-484

NIMHD

Dec 4, 2019

R01

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21)

PAR-17-483

NIMHD

Dec 4, 2019

R21

Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)

RFA-DA-19-002

NIDA

Jan 1, 2020

UG3/UH3

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)

PA-18-038

NICHD

Jan 7, 2020

R01

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)

PA-18-043

NICHD

Jan 7, 2020

R21

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)

PA-18-044

NICHD

Jan 7, 2020

R03

Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional)

PA-18-060

NIDA

Jan 7, 2020

R01

Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)

PA-18-078

NIDA

Jan 7, 2020

R21

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)

PAR-18-662

NCCIH

Feb 28, 2020

UG3/UH3

NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

PAR-18-118

NCCIH

Feb 29, 2020

U01

Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)

RFA-NS-18-041

NINDS

Mar 12, 2020

R61/R33

Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)

RFA-NS-18-046

NINDS

Mar 12, 2020

R61/R33

Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21)

PA-17-157

NIDA

May 7, 2020

R21

Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)

PA-17-155

NIDA

May 7, 2020

R01

Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional)

PA-18-061

NIDA

May 7, 2020

R01

Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional)

PA-18-079

NIDA

May 7, 2020

R21

Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional)

PA-18-080

NIDA

May 7, 2020

R03

Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)

RFA-DA-19-003

NIDA

Jul 17, 2020

R61/R33

Assay development and screening for discovery of chemical probes or therapeutic agents (R01)

PAR-17-438

NCI

Sep 7, 2020

R01

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 – Clinical Trials Required)

PAR-18-417

NCCIH

Sep 7, 2020

R34

Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)

PAS-18-624

NIDA

Sep 7, 2020

R01

Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional)

PAS-18-625

NIDA

Sep 7, 2020

R21

Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)

PAR-18-745

NIMHD

Nov 13, 2020

R21

Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)

PAR-18-747

NIMHD

Nov 13, 2020

R01

NINDS Exploratory Clinical Trials for Small Business (R44) – Clinical Trial Required

PAR-18-618

NINDS

Jan 5, 2021

R44

NINDS Exploratory Clinical Trials for Small Business (R42) – Clinical Trial Required

PAR-18-617

NINDS

Jan 5, 2021

R42

Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional)

PA-18-775

NIDA

Jan 7, 2021

R34

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp – Clinical Trial Optional)

PA-18-591

NIH

Jan 25, 2021

(Admin Supp)

Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional)

PAR-18-742

NIDA

Feb 11, 2021

R61/R33

HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)

RFA-NS-19-016

NINDS

Feb 22, 2021

UG3/UH3

HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)

RFA-NS-19-017

NINDS

Feb 22, 2021

U44

HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)

RFA-NS-19-018

NINDS

Feb 22, 2021

UH3

HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)

RFA-EB-18-003

NIBIB

Feb 22, 2021

U18

Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 – Clinical Trial Optional)

PAR-18-506

NICHD

May 7, 2021

R01

Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed)

PA-18-660

NIAAA

May 7, 2021

R01

Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional)

PA-18-687

NICHD

May 7, 2021

R03

Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional)

PA-18-688

NICHD

May 7, 2021

R01

International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional)

PA-18-773

NIDA

May 7, 2021

R01

Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 – Clinical Trial Optional)

PA-18-780

NIDA

May 7, 2021

R34

HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)

PAS-18-915

NIDA

Sep 7, 2021

R01

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 – Clinical Trial Optional)

PA-18-917

NIDA

Sep 7, 2021

R01

HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 – Clinical Trial Optional)

RFA-DA-19-019

NIDA

Sep 8, 2021

R43/R44

HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 – Clinical Trial Optional)

RFA-DA-19-020

NIDA

Sep 8, 2021

R41/R42

Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)

PAR-19-039

NINDS

Sep 14, 2021

U01

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)

PAR-19-040

NINDS

Sep 14, 2021

U01

Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)

PAR-19-064

NIDA

Nov 8, 2021

R21

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

PAR-19-100

NCATS

Nov 9, 2021

R21

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)

PAR-19-099

NCATS

Nov 9, 2021

U01

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

PA-18-932

ODP

Jan 7, 2022

R01

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)

PA-18-946

NINR

Jan 7, 2022

R21

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)

PA-18-945

NINR

Jan 7, 2022

R01

Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)

PA-18-943

NINR

Jan 7, 2022

R21

Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)

PA-18-944

NINR

Jan 7, 2022

R01

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional)

PAR-19-045

NINR

Jan 7, 2022

R01

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)

PAR-19-044

NINR

Jan 7, 2022

R21

 

UMKC Health Sciences District Research Council members

Dr. Jinwen Cai, Kansas City, Missouri Health Department

Dr. Kathy Goggin, Children’s Mercy Hospital

Dr. Mark Hecker, UMKC School of Medicine

Dr. Jessica Hellings, Truman Medical Centers Behavioral Health

Dr. Jianwei Jiao, Center for Behavioral Medicine

Dr. Joseph Lightner, UMKC School of Nursing and Health Studies

Dr. Russell Melchert, UMKC School of Pharmacy

Dr. Paula Monaghan-Nichols, UMKC School of Medicine

Dr. Mark Nichols, UMKC School of Medicine

Dr. Mark Steele, Truman Medical Centers

Dr. Mary Walker, UMKC School of Dentistry